iSpecimen Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.9M | $9.3M | $9.9M | $10.4M | $11.1M | $8.2M |
| Cost of Revenue | $1.7M | $5.1M | $4.8M | $4.8M | $5.2M | $3.6M |
| Gross Profit | $215.7K | $4.2M | $5.2M | $5.6M | $5.9M | $4.6M |
| Gross Margin | 11.2% | 45.0% | 51.9% | 54.3% | 52.9% | 56.2% |
| Operating Expenses | ||||||
| Research & Development | — | $1.5M | $1.6M | $1.5M | $879.2K | $319.2K |
| SG&A Expense | $3.5M | $6.1M | $5.9M | $6.9M | $5.6M | $2.4M |
| Operating Income | $-9.0M | $-12.7M | $-11.2M | $-10.2M | $-5.9M | $-2.4M |
| Operating Margin | -465.4% | -137.0% | -112.5% | -97.9% | -53.2% | -29.4% |
| Interest Expense | — | — | $16.0K | $239.0K | $2.1M | $2.1M |
| Pretax Income | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | $0 | $0 | $0 |
| Net Income | $-10.5M | $-12.5M | $-11.1M | $-10.2M | $-9.0M | $-4.7M |
| Net Margin | -543.7% | -134.5% | -111.8% | -98.5% | -80.5% | -56.8% |
| EPS (Basic) | $-2.28 | $-2.93 | $-4.09 | $-0.19 | $-0.17 | $-0.08 |
| EPS (Diluted) | $-2.28 | $-2.93 | $-4.09 | $-0.19 | $-0.17 | $-0.08 |
| Shares Outstanding (Basic) | 4.6M | 4.3M | 2.7M | 53.1M | 51.4M | 56.2M |
| Shares Outstanding (Diluted) | 4.6M | 4.3M | 2.7M | 53.1M | 51.4M | 56.2M |
| Dividends Per Share | — | — | — | — | — | — |